CONJESTINA ACHIENG WHAT AILS FORMER BOXING CHAMPION


 

CONJESTINA ACHIENG WHAT AILS FORMER BOXING CHAMPION – on Monday News At Eight brought you an exclusive story on Conjestina Achieng recent sorry condition. Today we explore her condition, state of mind and the possibility of curing it. We spoke to the psychiatrist and former Mathare Mental Hospital Director Dr. Peter Njagi who took time to watch Conjestina’s behaviours and say Conjestina does not show classical features of mental disorder. Dr. Peter Njagi is a psychiatrist and expert on alcohol, drug abuse treatment, former Director at Mathare mental hospital and currently the Director of Brightside Drug Abuse, rehabilitation and treatment centre

 

California Researchers Name Two Drugs that Make a Good 'First Treatment

Filed under: drug treatment news

A group of researchers from California found acamprosate (marketed as Campral) and naltrexone (ReVia) as good first option for treating people with alcohol problems. The two drugs are commonly used in treating alcoholism, are both non-addictive, and …
Read more on TestCountry.com (blog)

 

Local Ablation May Extend Drug Rx in NSCLC

Filed under: drug treatment news

Crizotinib has become standard systemic therapy for the subset of patients with ALK-positive NSCLC. However, reported progression-free survival (PFS) has ranged between 8 and 10 months, reflecting emergence of drug-resistant clonagens. In some …
Read more on MedPage Today

 

NHSO may add new drugs to national healthcare

Filed under: drug treatment news

The National Health Security Office's board will today study adding seven groups of drugs used to treat complex and rare diseases to the universal healthcare scheme that covers 48 million people. The NHSO has succeeded in saving Bt8.17 billion over the …
Read more on The Nation

 

Combining antiangiogenesis and anti-HER2 drugs may improve survival of

Filed under: drug treatment news

Adding an angiogenesis inhibitor to treatment with a HER2-inhibiting drug could improve outcomes for patients with HER2-positive breast cancer who develop brain metastases. In their report published online in PNAS Plus, Massachusetts General Hospital …
Read more on Bioscience Technology